Attached files
| file | filename |
|---|---|
| 10-K - ANNUAL REPORT - Citius Pharmaceuticals, Inc. | f10k2019_citiuspharma.htm |
| EX-32.2 - CERTIFICATION - Citius Pharmaceuticals, Inc. | f10k2019ex32-2_citiuspharma.htm |
| EX-32.1 - CERTIFICATION - Citius Pharmaceuticals, Inc. | f10k2019ex32-1_citiuspharma.htm |
| EX-31.2 - CERTIFICATION - Citius Pharmaceuticals, Inc. | f10k2019ex31-2_citiuspharma.htm |
| EX-31.1 - CERTIFICATION - Citius Pharmaceuticals, Inc. | f10k2019ex31-1_citiuspharma.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We
consent to the incorporation by reference in the Registration Statements on Forms S-1 (No.’s 333-224386, 333-226395,
333-230919 and 333-233759) and on Form S-3 (No. 333-221492) of Citius Pharmaceuticals, Inc. of our report dated December 16,
2019, relating to the consolidated financial statements of Citius Pharmaceuticals, Inc., appearing in the Annual Report on
Form 10-K for the year ended September 30, 2019.
| /s/ Wolf & Company, P.C. | |
| Wolf & Company, P.C. | |
| Boston, Massachusetts | |
| December 16, 2019 |